HFB2027

N/A

Report date: 2025/04/28 17:05:09
NME

Base Information

Drug NameHFB2027
Drug Alias NameHFB2027HFB-2027
ClassificationOther
Mechanisms of ActionTumor necrosis factor receptor superfamily member 1B agonists
TargetsTumor necrosis factor receptor superfamily member 1B
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesHiFiBiO Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesHiFiBiO Therapeutics
Inactive CompaniesN/A
Active IndicationsInflammation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A